Fact-checked by Grok 2 weeks ago

Transferrin saturation

Transferrin saturation, often abbreviated as TSAT, is a laboratory measure that represents the percentage of the iron-binding protein in the blood that is occupied by . It is calculated using the ( concentration divided by , or TIBC) multiplied by 100, providing an indirect assessment of status in the body. , a synthesized primarily in the liver, serves as the primary transporter of ferric (Fe³⁺) from sites of and to tissues such as the for synthesis. Normal reference ranges for TSAT vary slightly by sex and laboratory, but typically fall between 15% and 50% for females and 20% to 50% for males. In clinical practice, TSAT is a key component of iron panel testing, alongside serum and TIBC, to evaluate disorders of . Low TSAT values, generally below 20%, are indicative of , which may result from inadequate dietary intake, blood loss, , or increased demand such as in or chronic inflammation. Conversely, elevated TSAT levels exceeding 50% suggest conditions, including hereditary hemochromatosis, where excessive iron absorption leads to tissue deposition and potential organ damage. High TSAT has also been associated with increased risks of and mortality, particularly when combined with elevated . Beyond , TSAT plays a role in monitoring treatment responses for iron-related anemias and guiding therapeutic interventions like iron supplementation or . Variations in TSAT can be influenced by factors such as diurnal rhythms, recent iron intake, infections, or , which affect production and iron binding. As an acute-phase reactant, transferrin levels—and thus TSAT—may decrease during , complicating interpretation in certain patient populations. Overall, TSAT remains a valuable, non-invasive for assessing systemic iron and preventing complications from imbalance.

Overview

Definition

Transferrin saturation (TS) is a laboratory measure expressed as the percentage of transferrin molecules in the blood that are occupied by iron atoms. Transferrin serves as the principal glycoprotein in blood plasma for iron transport, binding two ferric iron (Fe³⁺) atoms per molecule with high affinity in a process stabilized by a carbonate ligand. This binding facilitates the delivery of iron to tissues such as the bone marrow, liver, and spleen, where it supports essential functions like hemoglobin synthesis. Unlike (TIBC), which assesses the maximum amount of iron that can bind in the blood under given conditions, transferrin saturation specifically indicates the proportion of available binding sites that are currently utilized by iron.

Physiological Role

represents the proportion of molecules in the that are bound to iron, serving as a key indicator of the body's iron supply relative to demand. Under normal conditions, approximately 30% of 's iron-binding sites are occupied, reflecting a balanced state where dietary iron matches the needs for and other cellular functions. This saturation level ensures that sufficient iron is available for synthesis in the while preventing excess free iron that could generate harmful . Iron absorption primarily occurs in the , where iron (Fe²⁺) enters enterocytes via the divalent metal transporter 1 (DMT1) and is exported across the basolateral membrane by (FPN1) as iron (Fe²⁺), which is then oxidized to ferric iron (Fe³⁺) extracellularly by the ferroxidase . Once in the plasma, Fe³⁺ binds to , which has two high-affinity binding sites per molecule, forming diferric transferrin. This iron-transferrin complex circulates and delivers iron to tissues by binding to transferrin receptor 1 (TfR1) on cell surfaces, such as those in the for production and the liver for storage. The complex undergoes clathrin-mediated , and within the acidic (pH ≈5.6), iron is released from transferrin via DMT1, entering the cytoplasm for utilization or storage as , while apo-transferrin (iron-free) recycles back to the plasma. The process is tightly regulated by , a liver-derived that maintains iron by controlling activity. When iron levels are high, hepcidin binds to ferroportin on enterocytes, macrophages, and hepatocytes, inducing its internalization and lysosomal degradation, which reduces iron export into the plasma and thereby lowers transferrin saturation. Conversely, during or increased demand (e.g., for ), hepcidin levels decrease, allowing ferroportin to export more iron, elevating plasma iron availability and transferrin saturation to meet tissue needs. This feedback mechanism prevents both iron deficiency and overload, ensuring efficient iron distribution throughout the body.

Measurement

Calculation

Transferrin saturation (TS) is calculated using the formula: \text{TS (\%)} = \left( \frac{\text{serum iron concentration}}{\text{total iron-binding capacity (TIBC)}} \right) \times 100 where serum iron is measured in micrograms per deciliter (µg/dL) and TIBC in the same units. Serum iron concentration quantifies the amount of iron present in the bloodstream, predominantly bound to transferrin as ferric ions (Fe³⁺), with negligible amounts of unbound or loosely bound iron. TIBC represents the maximum amount of iron that can be bound by transferrin in the serum under saturating conditions and is derived from the transferrin concentration, accounting for its two high-affinity binding sites per molecule; specifically, TIBC (µg/dL) ≈ transferrin concentration (mg/dL) × 1.25, where the factor 1.25 reflects the iron-binding stoichiometry adjusted for molecular weights (transferrin ≈ 79.5 kDa, iron atomic mass 55.85 Da). To derive TS step by step: First, measure to determine the currently bound iron fraction. Second, calculate or measure TIBC to estimate total available binding sites on , which serves as a for transferrin's iron-binding potential since it is the primary iron transporter (accounting for >99% of circulating iron binding). Third, divide by TIBC to obtain the proportion of binding sites occupied. Finally, multiply by 100 to express as a , indicating the degree of transferrin occupancy—low values suggest underutilization of sites (e.g., in ), while high values indicate near-full saturation. This computation provides a direct assessment of iron availability relative to transport capacity without requiring direct measurement of transferrin occupancy.

Laboratory Methods

Transferrin saturation is determined in clinical laboratories through the measurement of concentration and (TIBC), which are then used to compute the saturation value. is primarily quantified using colorimetric assays, where iron is released from and reduced to form a colored complex with reagents such as ferrozine or ferene, with measured at approximately 560-562 on automated analyzers. These methods involve liberating ferric iron (Fe³⁺) from using an -detergent mixture, reducing it to iron (Fe²⁺) with ascorbic , and forming a stable complex for photometric detection, achieving high precision with coefficients of variation typically ≤5%. Atomic spectrometry serves as an alternative technique, particularly for higher accuracy in settings, by directly measuring iron at specific wavelengths after sample . TIBC is assessed by saturating with excess iron and quantifying the total bound iron after removing unbound excess, often via with magnesium followed by and colorimetric measurement of the bound fraction. This indirect method, widely implemented on automated systems like the Alpkem Flow Solutions or Cobas analyzers, involves mixing with a standardized iron (e.g., μg/dL), adsorbing free iron, and detecting the -bound iron using ferrozine-based reagents. Alternatively, TIBC can be derived from direct of levels using immunoturbidimetric or nephelometric techniques, which detect protein concentration via antibody-antigen reactions on platforms, offering advantages in cases of abnormal iron-binding proteins. Blood samples for these assays are collected via into plain or serum separator tubes, with a state preferred to minimize diurnal variations in iron levels, which can fluctuate up to 30% throughout the day, and morning draws are recommended for consistency. should be separated from cells within 2 hours to prevent artifactual changes, and hemolyzed samples must be avoided as they falsely elevate iron readings due to erythrocyte release. Recent iron supplementation or intake can interfere by acutely increasing , while storage at 2-8°C allows stability for up to 3 weeks, or longer if frozen at -20°C.

Reference Values

Normal Ranges

Transferrin saturation is typically reported as a (%) and represents the proportion of that is bound to iron. In healthy adults, the standard reference interval is 20% to 50% for males and 15% to 50% for females, reflecting slight sex-based differences in iron and . These ranges are established through large-scale population studies of iron status in non-anemic individuals. Age-specific norms vary significantly. Newborns exhibit higher transferrin saturation levels, often ranging from approximately 50% at birth and reaching up to 80% or more in some cases, due to the transplacental iron transfer during late gestation that supports rapid postnatal growth. These elevated values stabilize by , aligning with adult ranges around 6 months to 1 year of as iron demands and patterns mature. In the elderly, transferrin saturation tends to be lower within the reference interval, often influenced by subclinical inflammation that suppresses iron release from stores, though the standard adult ranges generally apply unless adjusted for comorbidities. Reference intervals can exhibit lab-specific variations depending on the assay method, such as spectrophotometric versus immunoturbidimetric techniques for measuring and , which may shift the upper or lower bounds by 5-10%. Laboratories typically validate these ranges against local healthy populations to ensure accuracy.

Influencing Factors

Transferrin saturation (TSAT) exhibits circadian rhythms, with levels peaking during the active phase—typically higher in the morning—and reaching troughs during rest, reflecting endogenous regulation tied to and hepatic transferrin receptor expression. This diurnal variation can cause fluctuations of up to 17% from peak to trough, independent of external light cues. In premenopausal women, TSAT varies across the due to hormonal influences on iron regulation; levels are typically lower in the early following blood loss, then increase through the mid-to-late as suppresses to enhance iron availability, before plateauing in the under progesterone's effects. These cyclic changes highlight the role of reproductive hormones in modulating iron parameters without underlying . During , TSAT decreases primarily due to hemodilution from a 30–50% expansion in plasma volume, contributing to physiologic by the third in unsupplemented women. This decline is further influenced by reduced maternal in later trimesters, which prioritizes iron transfer to the fetus. Recent iron supplementation can elevate TSAT by increasing levels, aiding replenishment of stores after depletion without indicating overload. Similarly, a high in bioavailable iron, such as from sources, transiently raises postprandial and TSAT, particularly if consumed shortly before sampling. During recovery from acute non-pathological loss, such as from minor injury or donation, TSAT gradually normalizes as iron intake restores circulating levels. Methodological factors also influence TSAT measurements; within-person biological variability can reach approximately 30%, while inter-laboratory assay differences arise from variations in colorimetric methods for and , leading to inconsistencies across clinical analyzers. Sample handling errors, including delayed processing or improper storage, may artifactually alter results, as may , which releases erythrocyte iron and inflates concentrations used in TSAT calculations. samples are recommended to minimize acute dietary effects on these measurements.

Clinical Interpretation

Low Saturation

Low transferrin saturation, typically defined as a value below 20%, signifies inadequate iron availability for binding to molecules in the bloodstream. This threshold indicates that a substantial proportion of remains unoccupied, impairing the efficient transport of iron to tissues that require it for essential functions such as oxygen delivery and enzyme activity. Biochemically, low transferrin saturation arises from a relative decrease in concentration compared to the (TIBC), which is largely determined by levels. In response to iron scarcity, the liver upregulates synthesis to maximize iron capture, yet the available iron remains insufficient to saturate the increased binding sites, often reflecting depleted bodily iron stores. Individuals with low transferrin saturation may experience symptoms such as and , particularly when this occurs in the context of , due to compromised production and reduced oxygen-carrying capacity of the blood. However, these manifestations are nonspecific and not diagnostic on their own, as they can stem from various underlying physiological disruptions. In clinical practice, low saturation serves as an initial indicator in broader iron status assessments to guide further diagnostic evaluation.

High Saturation

High transferrin saturation, typically defined as exceeding 45% in women and 50% in men, signifies an excess of relative to the binding capacity of . This threshold indicates that a substantial portion of molecules are fully occupied by iron, reflecting an imbalance in iron where circulating iron surpasses the protein's transport limits. Biochemically, elevated overwhelms the two high-affinity binding sites on each molecule, which normally sequesters iron to prevent during transport to tissues. In cases of severe , when transferrin saturation is very high (typically exceeding 70-80%), non-transferrin-bound iron (NTBI) may emerge in the plasma, comprising low-molecular-weight forms such as iron-citrate complexes that are not bound to . This NTBI represents a shift from regulated iron delivery, allowing unbound iron to enter cells via alternative pathways like L-type calcium channels. The presence of NTBI carries risks of oxidative stress, as free iron facilitates the Fenton reaction, generating hydroxyl radicals and other reactive oxygen species that damage lipids, proteins, and DNA. Despite these potential hazards, high transferrin saturation often remains asymptomatic in early phases, with clinical manifestations arising only after prolonged iron accumulation. High transferrin saturation serves as a key marker in screening for iron overload disorders.

Clinical Significance

Diagnostic Applications

Transferrin saturation (TS) serves as a key initial screening tool for hereditary hemochromatosis, where levels exceeding 45% typically prompt for HFE mutations to confirm the . In the context of , a low TS (typically <16-20%) combined with reduced serum ferritin levels provides confirmatory evidence of absolute iron deficiency, guiding the initiation of iron supplementation. In chronic conditions, TS is routinely monitored to assess iron status, particularly in chronic kidney disease (CKD), where TSAT ≤30% alongside ferritin levels ≤500 ng/mL indicates iron deficiency warranting intravenous iron therapy to support erythropoiesis. Similarly, in heart failure, iron deficiency is defined as TS <20% with ferritin 100-299 ng/mL, and serial TS measurements help evaluate the need for iron repletion to improve symptoms and outcomes. In inflammatory states, such as chronic infections or autoimmune diseases, a TS <20% can signal functional iron deficiency despite normal or elevated ferritin due to hepcidin-mediated iron sequestration, aiding in the differentiation from anemia of chronic disease. Therapeutically, TS guides the response to interventions; in iron deficiency, successful oral or intravenous iron therapy typically raises TS toward normal ranges (20-50%) within weeks, confirming adequate absorption and utilization. In hereditary hemochromatosis, phlebotomy is continued until TS normalizes below 50%, with ongoing monitoring to maintain levels under 70% during maintenance therapy and prevent recurrence of iron overload.

Relation to Other Tests

Transferrin saturation (TS) is a key component of the iron panel, which typically includes , total iron-binding capacity (TIBC), and to provide a comprehensive evaluation of iron status. In this panel, TS reflects the proportion of transferrin bound to iron, calculated from serum iron and TIBC, and helps interpret iron availability in relation to transport capacity. For instance, low TS combined with low serum iron and high TIBC typically indicates , as the body increases transferrin production to capture scarce iron. Conversely, high TS with high serum iron and low TIBC suggests , where transferrin becomes fully saturated and binding capacity is reduced. TS aids in differentiating iron deficiency anemia from anemia of chronic disease by integrating with ferritin measurements. In iron deficiency, low TS (often <20%) pairs with low ferritin (<30 ng/mL), confirming depleted iron stores. In anemia of chronic disease, TS is typically normal or low (<20%), but ferritin is elevated (>100 ng/mL) due to inflammation-induced of iron, distinguishing it from true deficiency. This combination allows clinicians to avoid misdiagnosis, as serum iron alone can be low in both conditions. However, TS has limitations when used in isolation, particularly in inflammatory states, where it may underestimate if is artifactually elevated as an acute-phase reactant. Guidelines from the recommend combining TS with and, if needed, soluble transferrin receptor levels for accurate assessment in such cases, using thresholds like TS <20% and 30–100 ng/mL with elevated to identify functional . This integrated approach enhances diagnostic precision across various clinical scenarios.

References

  1. [1]
    Biochemistry, Transferrin - StatPearls - NCBI Bookshelf - NIH
    Jul 7, 2025 · High transferrin saturation increases the risk of cardiovascular mortality if patients have high transferrin saturation (>55%) and low-density ...
  2. [2]
    Transferrin Saturation: Reference Range, Interpretation, Collection ...
    Oct 27, 2025 · Transferrin saturations of less than 20% indicate iron deficiency, while transferrin saturations of more than 50% suggest iron overload.
  3. [3]
    Serum iron test: MedlinePlus Medical Encyclopedia
    Mar 31, 2024 · Normal value range is: Iron: Males: 50 to 150 mcg/dL (8.95 to 26.85 ... Iron saturation: Males: 20% to 50%; Females: 15% to 45%. The ...
  4. [4]
    Iron-Binding Capacity - StatPearls - NCBI Bookshelf
    May 2, 2024 · Following a short period of equilibration, the serum sample (transferrin) is saturated with iron; the affinity of iron for the serum transferrin ...
  5. [5]
    Current understanding of iron homeostasis - PMC - PubMed Central
    Iron-loaded transferrin binds to transferrin receptor 1 on the surface of most body cells, and after endocytosis of the complex, iron enters the cytoplasm via ...
  6. [6]
    Hepcidin Regulation of Iron Transport - PMC - NIH
    Hepcidin inhibits iron release at both of these sites by binding to cell-surface ferroportin and causing its internalization and subsequent degradation.
  7. [7]
    Iron Panel (IRON, TRANSFERRIN, TIBC and % SATURATION)
    Apr 25, 2019 · In hereditary hemochromatosis, serum iron is usually > 150 μg/dL and iron (transferrin) saturation is greater than 60%. In advanced iron ...
  8. [8]
    The alteration of ferritin and transferrin saturation under body mass ...
    May 31, 2019 · ... 1.25- and 1.18-fold higher serum ferritin levels, respectively. ... Serum TIBC (ug/dL) was calculated as serum transferrin using the formula TIBC ...
  9. [9]
    Laboratory methodologies for indicators of iron status
    Transferrin saturation is calculated as the ratio of iron to transferrin or iron to total iron-binding capacity; if unsaturated iron-binding capacity is ...
  10. [10]
    [PDF] L. Serum Iron (Refrigerated) Laboratory Procedure Manual - CDC
    The Roche method of iron measurement is a three step process using FerroZine reagent: Fe3+ is liberated from transferrin by acid/detergent, Fe3+ is reduced to ...<|control11|><|separator|>
  11. [11]
    [PDF] Lab 06 Iron and TIBC - CDC
    In TIBC tests, serum is mixed with 400 µg/dL iron solution to saturate the iron-binding sites of the serum transferrin molecules. Magnesium carbonate is used to ...
  12. [12]
    Pediatric Reference Intervals for Transferrin Saturation in the ... - NIH
    The percentage of these iron binding sites occupied by iron is defined as the transferrin saturation. Determining levels of iron and TIBC, and calculating ...
  13. [13]
    HFE gene mutation and transferrin saturation in very low birthweight ...
    Ten infants had a transferrin saturation above 80% at least once. No infant was positive for both transferrin saturation above 80% and the mutation.
  14. [14]
    Iron homeostasis in full-term, normal birthweight Gambian neonates ...
    Jun 26, 2023 · ... birth to 7.3 ± 4.6 µmol/L during the first 6–24 h after birth) and transferrin saturation (50.2 ± 16.7% to 14.4 ± 6.1%). Both variables ...Results · Changes In Hepcidin And... · Subjects And Methods<|separator|>
  15. [15]
    Pediatric Reference Ranges - UI Health Care
    Iron (Transferrin) Saturation, All ages, 20–50, 15–50, %. Total Protein, Birth–31 days, 4.1–6.3, 4.2–6.2, g/dL. 1–6 months, 4.7–6.7, 4.4–6.6, g/dL. 6 months–1 ...
  16. [16]
    Iron status in the elderly - PMC - PubMed Central
    The next stage of deficiency is iron-deficient erythropoiesis, characterised by reduced transferrin saturation.
  17. [17]
    [PDF] REFERENCE VALUES FOR COMMON LABORATORY TESTS1
    Transferrin saturation. All ages. 10–50%. Uric acid, serum. Newborn–14 years. 1–7 mg/dL. Hematology. Age. Hemoglobin. (g/dL). Hematocrit. (%). RBC. (× 106 cells ...
  18. [18]
    Serum iron and transferrin saturation variation are circadian ...
    Aug 17, 2024 · This study provides the first confirmatory evidence that serum iron is circadian regulated, discerns circadian rhythms of TSAT, a widely used clinical marker ...<|separator|>
  19. [19]
    A contemporary understanding of iron metabolism in active ...
    The reproductive hormones estrogen and progesterone influence iron regulation and contribute to variations in iron parameters throughout the menstrual cycle.
  20. [20]
    Iron homeostasis during pregnancy - PMC - NIH
    Physiologic anemia of pregnancy occurs during a healthy pregnancy as a consequence of ... diurnal variation, and can change rapidly, e.g., after iron ingestion.
  21. [21]
    Iron Deficiency Anemia - StatPearls - NCBI Bookshelf
    Aug 7, 2023 · Iron supplementation is needed for at least three months to replenish tissue iron stores and should proceed for at least a month even after ...
  22. [22]
    Iron deficiency | Blood | American Society of Hematology
    Jan 3, 2019 · The minimal dose used for iron supplementation is 60 mg per day. Lower doses (37.5 mg per day) of oral iron have proven useful in blood donors ...
  23. [23]
    Iron Metabolism in the Recovery Phase of Critical Illness with ... - MDPI
    Since transferrin can stand without binding iron, transferrin saturation (TSAT) reflects the amount of iron bound to transferrin, and is used as a reliable ...Iron Metabolism In The... · 3. Iron Metabolism In... · 4.3. Transferrin And...
  24. [24]
    Transferrin Saturation - an overview | ScienceDirect Topics
    A transferrin saturation < 15% is consistent with iron deficiency or inflammation. Values > 45% suggest increased iron stores, recent iron ingestion, diurnal ...
  25. [25]
    The Evaluation of Iron Deficiency and Iron Overload - PMC
    Transferrin saturation (TSAT) is an important biomarker of iron availability. Iron deficiency is present if the TSAT is less than 20%, and iron overload if it ...
  26. [26]
    Pathogenic Mechanisms Underlying Iron Deficiency and Iron Overload
    In iron deficiency, serum Tf concentrations are elevated while iron concentrations are decreased, resulting in a decreased Tf saturation. However serum iron ...
  27. [27]
    Iron deficiency without anaemia: a diagnosis that matters - PMC - NIH
    Transferrin saturation (TSAT) levels below 20% are also diagnostic of ID. In chronic inflammatory conditions when ferritin levels are 100–300 μg/L, TSAT should ...Causes Of Iron Deficiency · Clinical Features · Preoperative Iron Deficiency<|control11|><|separator|>
  28. [28]
    Hemochromatosis - Diagnosis and treatment - Mayo Clinic
    Jan 9, 2025 · Serum transferrin saturation. This test measures the amount of iron bound to the protein transferrin that carries iron in the blood. Transferrin ...
  29. [29]
    Hyperferritinemia—A Clinical Overview - PMC - PubMed Central
    May 7, 2021 · ... elevated transferrin saturation can usually confirm this. Transferrin saturation >45% in women and >50% in men is generally regarded as ...3. Etiology · 3.2. 1. Primary Iron... · 5. Diagnostic WorkupMissing: threshold | Show results with:threshold
  30. [30]
    Transfusion Iron Overload - StatPearls - NCBI Bookshelf
    Feb 12, 2024 · A transferrin saturation of over 50% indicates a high iron load. However, this is a dynamic number and could vary with inflammation. NTBI and ...Transfusion Iron Overload · History And Physical · ComplicationsMissing: threshold | Show results with:threshold
  31. [31]
    The role of mitochondria in iron overload-induced damage - PMC
    Nov 25, 2024 · When transferrin reaches iron saturation, a condition known as iron overload occurs, resulting in increased levels of non-transferrin bound iron ...
  32. [32]
    Increased Levels of Circulating Iron-Albumin Complexes in ... - NIH
    Feb 16, 2023 · By promoting reactive oxygen species (ROS) and reactive nitrogen species (RNS) formation, NTBI causes oxidative stress and alteration of ...Missing: threshold | Show results with:threshold
  33. [33]
    Iron as an emerging therapeutic target in critically ill patients - NIH
    Dec 4, 2023 · This release of NTBI can induce oxidative stress and cellular damage in the kidneys, which can be aggravated during the reperfusion phase as ...Missing: threshold | Show results with:threshold
  34. [34]
    The Relationship Between Non-Transferrin-Bound Iron (NTBI ...
    Both NTBI and LPI contribute to oxidative stress by participating in free-radical-generating reactions.
  35. [35]
    Hereditary Hemochromatosis: Rapid Evidence Review - AAFP
    Transferrin saturation of greater than 45% is often the earliest laboratory abnormality detected. Ferritin levels greater than 300 ng per mL (300 mcg per L) in ...
  36. [36]
    EASL Clinical Practice Guidelines on haemochromatosis
    May 31, 2022 · The first step in testing for haemochromatosis is the assessment of serum iron parameters, which should include transferrin saturation and serum ...
  37. [37]
    Iron Deficiency Anemia: Evaluation and Management - AAFP
    Jan 15, 2013 · Values consistent with iron deficiency include a low serum iron level, low transferrin saturation, and a high total iron-binding capacity.
  38. [38]
    A guide to diagnosis of iron deficiency and iron deficiency anemia in ...
    Low serum levels of ferritin or transferrin saturation, imply a situation of absolute or functional ID. It is sometimes difficult to differentiate ID anemia ...
  39. [39]
    [PDF] kdigo 2025 clinical practice guideline for anemia in chronic kidney ...
    Test for anemia with the following set: complete blood count (CBC), reticulocytes, ferritin, transferrin saturation (TSAT) (Figure 6). Figure 5 | Suggested ...
  40. [40]
    Diagnosis and management of iron deficiency in chronic ...
    Dec 4, 2020 · WHO guidelines recommend a ferritin level <15 μg/L as a sign of absolute ID in adults,8 although a cutoff of 30 μg/L is more often used because ...
  41. [41]
    Criteria for Iron Deficiency in Patients With Heart Failure - JACC
    Jan 24, 2022 · Guidelines on heart failure (HF) define iron deficiency (ID) as a serum ferritin <100 ng/mL or, when 100-299 ng/mL, a transferrin saturation (TSAT) <20%.
  42. [42]
    How to diagnose iron deficiency in chronic disease: A review of ...
    Jan 9, 2023 · The most commonly used threshold values for the diagnosis of ID are TSAT of < 20% and serum ferritin of < 100–300 μg/L.Diagnosis Of Iron Deficiency · Stfr--Ferritin Index · Iron Deficiency Diagnosis...<|control11|><|separator|>
  43. [43]
    How I treat hemochromatosis | Blood - ASH Publications
    Jul 22, 2010 · Monitoring iron measures during phlebotomy therapy​​ Transferrin saturation is increased in most patients with hemochromatosis who have ...
  44. [44]
    Patients with hereditary hemochromatosis reach safe range of ... - NIH
    For the maintenance treatment of patients with hereditary hemochromatosis (HH), it is advised to keep the transferrin saturation (TSAT) <70% to prevent ...
  45. [45]
    Iron and Total Iron-binding Capacity (TIBC) | Labcorp Test 001321 ...
    Sep 30, 2025 · The combination of low iron, high TIBC and/or transferrin and low saturation indicates iron deficiency. Without all of these findings together, ...
  46. [46]
    Iron Deficiency Anemia and Anemia of Chronic ... - ARUP Consult
    The workup to distinguish between IDA and ACD/AI includes ferritin, iron and iron binding capacity, and serum soluble transferrin receptor testing.
  47. [47]
    Differentiation of Iron Deficiency and the Anemia of Chronic Disease
    Iron deficiency, determined by serum ferritin of 20 ng/mL or less, was present in only 31 percent of patients with a serum iron level of 10 micrograms/dL or ...
  48. [48]
    Diagnosis and management of iron deficiency in chronic ... - NIH
    Dec 4, 2020 · Transferrin saturation (TSAT) <6% in combination with low ferritin is diagnostic of ID, but in the presence of inflammation, a seemingly ...Missing: recovery | Show results with:recovery